New therapy halts progression of Lou Gehrig's disease in mice

(Oregon State University) Researchers announced today that they have essentially stopped the progression of amyotrophic lateral sclerosis (ALS), or Lou Gehrig's disease, for nearly two years in one type of mouse model used to study the disease -- allowing the mice to approach their normal lifespan. The findings are compelling and promising, scientists say.